TWM
KYNB

Tolleson Wealth Management’s Kyntra Bio KYNB Stock Holding History

Tolleson Wealth Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,871
Closed -$2.95M – 69
2020
Q3 		$2.95M Sell
2,871
-821
-22% -$883K 1.19% 19
2020
Q2 		$3.74M Hold
3,692
– – 1.64% 12
2020
Q1 		$3.21M Hold
3,692
– – 1.4% 14
2019
Q4 		$3.96M Sell
3,692
-1,950
-35% -$1.99M 1.92% 11
2019
Q3 		$5.22M Sell
5,642
-627
-10% -$689K 2.84% 7
2019
Q2 		$7.08M Buy
6,269
+4,102
+189% +$4.49M 4.88% 4
2019
Q1 		$2.94M Sell
2,167
-241
-10% -$327K 2.04% 7
2018
Q4 		$2.79M Buy
+2,408
New +$2.71M 1.64% 12

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Tolleson Wealth Management's KYNB Position: Q4 2020 in Review

Tolleson Wealth Management sold out of Kyntra Bio (KYNB) in Q4 2020, closing a stake of 2,871 shares — an estimated $2.95M sold.

Tolleson Wealth Management first reported a position in KYNB in Q4 2018 and held it in 8 quarters. The position peaked at $7.08M in Q2 2019. 207 funds tracked by Wall St. Rank hold KYNB as of Q4 2020.

  • Tolleson Wealth Management reported no remaining Kyntra Bio position as of Q4 2020 after selling out during the quarter.
  • Tolleson Wealth Management sold 2,871 Kyntra Bio shares in Q4 2020, an estimated $2.95M.
  • Tolleson Wealth Management first reported a position in Kyntra Bio in Q4 2018 and held it in 8 quarters.
  • Tolleson Wealth Management's Kyntra Bio position peaked at $7.08M in Q2 2019.
  • 207 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2020.

Based on Tolleson Wealth Management's 13F filing for Q4 2020, filed 16 Feb 2021.